Shandong Qilu King-Phar

Qilu King-Phar Pharmaceutical is a major Chinese pharmaceutical manufacturer and a key subsidiary of the Qilu Pharmaceutical Group. The company specializes in the large-scale production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms, with a particular emphasis on fermentation-based products and anti-infectives. Their portfolio includes a wide range of antibiotics, such as cephalosporins and aminoglycosides, as well as treatments for cardiovascular and metabolic diseases. Operating out of significant manufacturing bases in Shandong, the company provides contract manufacturing services and exports products to numerous international markets, maintaining compliance with global GMP standards.